David Twesigomwe retweeted
The last of our @H3Africa /GSK ADME Project papers, "Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub‐Saharan African Populations" has just appeared. ascpt.onlinelibrary.wiley.co…
Such a treat attending the Mutational Scanning Symposium #VariantEffect23 at the @wellcomegenome with colleagues based at @mrc_hgu @EdinburghUni
Congrats to these talented young scientists on their graduation yesterday #MscMed_GenomicMedicine #classof2022 @WitsHealthFac
David Twesigomwe retweeted
Looking forward to hosting @atelvee in our next #AfriPopGenWebinar on June 22, 2023 at 3pm CAT!
Register to join at: tinyurl.com/afripopgen-webin…
@asbcb1 @H3Africa @AfSHGenetics @GeneMAPOfficial @WACCBIP_UG @H3ABioNet @ICHG2023
So excited to present our #PGx poster on CYP2D6, CYP2B6, and CYP2A6 star allele characterisation in African populations at #ESHG2023. Wonderful meeting great colleagues @ChantalResearch and @synthymama 🙂
Such an honour sharing this moment with my PhD supervisors @shazeZA and @dl_zane! Thanks also to my friends, family, colleagues and mentors for the great guidance and support.
Congratulations to the @SBIMB1’s @TwesiDave for winning the most prestigious PhD thesis in the @WitsHealthFac prize giving for 2022
David Twesigomwe retweeted
Very excited to host @cschlebu from @HumanEvoUU for our next #webinar on May 4, 2023 at 3pm CAT!
Register to join at: tinyurl.com/afripopgen-webin…
@asbcb1 @H3Africa @AfSHGenetics @H3Africa @SAHumanGenetics @GeneMAPOfficial @humangeneticstz @genome_gov @TACG_Group @GenomicsEngland
David Twesigomwe retweeted
We @MRC_Uganda with @eventsWCS @AceUganda @Makerere are organising a Polygenic Risk Score (PRS) analysis workshop in Uganda.
The course is subsidised by Wellcome Connecting Science Courses and Conferences and is FREE to attend.
APPLY and Join us in Uganda
@H3Africa
Such an honour presenting at the @H3ABioNet 10 year symposium! H3ABioNet has greatly contributed to my bioinformatics training, and opened doors for collaboration with (and learning from) scientists @UVRIug, @SBIMB1, @HPCBio, across Africa and beyond.
#H3ABioNet10YearImpact
Replying to @TwesiDave
@TwesiDave and Nhamulo gave great presentations to the @H3ABioNet symposium on tools developed at @SBIMB1 to support African pharmacogenomics
David Twesigomwe retweeted
I'm very chuffed that the @SBIMB1 has contributed to two articles in Clinical Pharmacology & Therapeutics (
@ASCPT_ClinPharm) special issue on Diversity, Equity and Inclusion.
David Twesigomwe retweeted
Funded PhD project announcement time! Two potential projects available, @wellcometrust Public Health Genomics PhD prog @uniofleicester. Applicants from low-middle income countries welcome. @H3Africa @AfSHGenetics @SAHumanGenetics @eshgsociety @GeneticsSociety Please RT! 1/6
It was great meeting you too @SFatumo! Your mentorship and support of young African scientists is making a difference and setting a great example for us.
Great to catch up with long time colleagues @manuelcorpas @TwesiDave @SBIMB1 at the @GenomicsEngland diverse data event #RGEC22 in London today.
Our #PGx paper on the Characterization of POR haplotype distribution in African populations is now out @PGSjournal. Congrats to @RossBooyse for excellently leading this research—such a pleasure co-supervising him with @shazeZA, @SBIMB1 @WitsHealthFac.
doi.org/10.2217/pgs-2022-008…
Five novel rare POR haplotypes were computationally inferred from the African WGS data; five other unresolved diplotypes contained novel African-ancestry POR alleles. More novel POR alleles were identified in African populations compared to other global populations.
This study highlights the distribution of POR star alleles in Africa and across global populations with a view toward informing future precision medicine implementation. Standardisation of the POR allele nomenclature is warranted given the #PGx importance of this gene.
David Twesigomwe retweeted
So wonderful to meet with old and new colleagues and hear about exciting research being done at the Wits University Research Day.























